Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
Open Access
- 11 September 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (20) , 11563-11568
- https://doi.org/10.1073/pnas.201167798
Abstract
The PTEN gene encodes a lipid phosphatase that negatively regulates the phosphatidylinositol 3-kinase pathway and is inactivated in a wide variety of malignant neoplasms. High rates of loss of heterozygosity are observed at the 10q23.3 region containing the human PTEN gene in prostate cancer and other human malignancies, but the demonstrated rate of biallelic inactivation of the PTEN gene by mutation or homozygous deletion is significantly lower than the rate of loss of heterozygosity. The transgenic adenocarcinoma of mouse prostate model is a well characterized animal model of prostate cancer. Analysis of prostate cancer progression in transgenic adenocarcinoma of mouse prostate mice bred to Pten+/− heterozygous mice, coupled with analysis of the Pten gene and protein in the resulting tumors, reveals that haploinsufficiency of the Pten gene promotes the progression of prostate cancer in this model system. This observation provides a potential explanation for the discordance in rates of loss of heterozygosity at 10q23 and biallelic PTEN inactivation observed in prostate cancer and many human malignancies.Keywords
This publication has 35 references indexed in Scilit:
- Absence of PTEN/MMAC1 Pseudogene in MiceDNA and Cell Biology, 2000
- FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cellsJournal of Cellular Physiology, 1999
- Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systemsProceedings of the National Academy of Sciences, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- PTEN and prostate cancer.Journal of Medical Genetics, 1998
- Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomasOncogene, 1998
- PTEN/MMAC1/TEP1 involvement in primary prostate cancersOncogene, 1998
- Analysis of PTEN and the 10q23 region in primary prostate carcinomasOncogene, 1998
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997